Koios Pharmaceuticals Receives Favorable Ruling in Challenge to High-Cost Druga s Patent

… spent $30.2 billion on specialty autoimmune medicines like Rasuvo, Humira, and Enbrel in 2015, according to IMS Health, and spending on autoimmune treatments grew 28% from the prior year-more quickly than any other treatment category. Koios’s …